Bush is the first president in 150 years to go an entire term without vetoing a single bill, but if progress on stem-cell legislation stays on track, we’ll see his first one soon.
A controversial bill to hike funding for stem-cell research is gaining momentum in the House, increasing the chances that it will be the first bill President Bush vetoes.
The bill, sponsored by Reps. Mike Castle (R-Del.) and Diana DeGette (D-Colo.), has 186 co-sponsors, including 20 Republicans, and a Democratic aide tracking the bill predicted the legislation will eventually secure a majority of the House. Most of those votes are expected to come from House Democrats.
Because a Senate version of the bill already has 58 co-sponsors, many political observers expect the bill to reach the president’s desk if it clears the House.
Bush hasn’t officially warned lawmakers that he’d veto the legislation. Indeed, as far as I can tell, the White House is ignoring the bill’s existence. But the numbers here speak for themselves — proponents of funding stem-cell research have the votes to pass the bill in both chambers and Speaker Dennis Hastert has promised sponsors a floor vote. This thing, in other words, looks like it is eventually going to pass.
Which would put the White House is in a very uncomfortable position.
Because Bush hasn’t vetoed anything, there’d be more attention than usual for this presidential rejection. It would mean front-page news across the country that a bi-partisan bill to expand federal funding for life-saving medical research reached the president’s desk — but because the religious right insists a blastocyst is a person, the president refused to sign it into law. This, despite broad public support for the research, plus the support of high-profile conservatives like Orrin Hatch and Nancy Reagan.
Would Bush really risk the political backlash? Does he really want to tell the nation that he’d reject popular, bi-partisan legislation that could save lives because James Dobson has Karl Rove on speed dial?
Time will tell.